Search

BACKGROUND: Both tenofovir alafenamide (TAF) and tenofovir disoproxil fumarate (TDF) are the first-line treatments for chronic hepatitis B (CHB). We have showed switching from TDF to TAF for 96 weeks resulted in further alanine aminotransferase (ALT) improvement, but data remain lacking on the long-term benefits of TDF switching to TAF on hepatic fibrosis. AIM: To assess the benefits of TDF switching to TAF for 3 years on ALT, aspartate aminotransferase (AST), and hepatic fibrosis improvement in patients with CHB. METHODS: A single center retrospective study on 53 patients with CHB who were initially treated with TDF, then switched to TAF to determine dynamic patterns of ALT, AST, AST to platelet ratio index (APRI), fibrosis-4 (FIB-4) scores, and shear wave elastography (SWE) reading improvement at switching week 144, and the associated factors. RESULTS: The mean age was 55 (28-80); 45.3%, males; 15.1%, clinical cirrhosis; mean baseline ALT, 24.8; AST, 25.7 U/L; APRI, 0.37; and FIB-4, 1.66. After 144 weeks TDF switching to TAF, mean ALT and AST were reduced to 19.7 and 21, respectively. From baseline to switching week 144, the rates of ALT and AST < 35 (male)/25 (female) and < 30 (male)/19 (female) were persistently increased; hepatic fibrosis was also improved by APRI < 0.5, from 79.2% to 96.2%; FIB-4 < 1.45, from 52.8% to 58.5%, respectively; mean APRI was reduced to 0.27; FIB-4, to 1.38; and mean SWE reading, from 7.05 to 6.30 kPa after a mean of 109 weeks switching. The renal function was stable and the frequency of patients with glomerular filtration rate > 60 mL/min was increased from 86.5% at baseline to 88.2% at switching week 144. CONCLUSION: Our data confirmed that switching from TDF to TAF for 3 years results in not only persistent ALT/AST improvement, but also hepatic fibrosis improvement by APRI, FIB-4 scores, as well as SWE reading, the important clinical benefits of long-term hepatitis B virus antiviral treatment with TAF.

Life table parameters of Amblyseius swirskii when Frankliniella occidentalis and Tetranychus urticae were offered solely as diet were investigated. The switching behaviour of this predator was studied on F. occidentalis in the presence of spider mites. The data showed that feeding on the spider mite resulted in significantly longer developmental time compared to thrips. We found a significant effect of prey on the total life span, adult pre-oviposition period (APOP), and total pre-oviposition period (TPOP) of the predatory mite. The length of the oviposition period and the number of laid eggs per female were not affected by the kind of the offered prey. None of population growth parameters was affected by the type of diet except for mean generation time (T). Predators fed on spider mite had a longer T than those reared on thrips. Furthermore, our data illustrated a negative switching in the behaviour of A. swirskii when T. urticae and F. occidentalis were present. In other words, the predator switched from the abundant prey to the rarer prey. The results of this study are needed to understand and forecast the performance of A. swirskii in greenhouse environments where both T. urticae and F. occidentalis can be present. [ABSTRACT FROM AUTHOR]

The design integration of absorption and adsorption cooling systems is a recently emerging research field in which the inherent advantages of both these systems are intended to be combined so as to maximize system performance. However, a vast majority of the conventional integration approaches reported in the literature still suffer from the following drawbacks: (a) the inability to provide a continuous cooling effect of the integrated design during the switching period of the adsorption component, (b) the lack of incorporation of the mass/heat recovery cycles and its subsequent effects upon the integrated performance, and (c) the lack of functional dependence of all thermodynamic variables including heat capacities and adsorption enthalpy upon operational parameters such as temperature and pressure. This study presents the first attempt of a numerically validated performance prediction of such an integrated system with parallel functionality to facilitate a continuous cooling operation. An empirical model of mass recovery cycle has been formulated for the very first time which adequately describes the sorption dynamics during mass transfer. All thermodynamic variables have been expressed as functions of operational parameters during the cooling cycle. For a mean driving temperature predicted to be as low as 38 °C and a mean cycle time of 11.82 min, the proposed integrated design has been predicted to yield a cycle-averaged specific cooling power of 48.93 W kg−1 and a minimum achievable coefficient of performance of 0.74 compared to the corresponding values of 27.64 W kg−1 and 0.57 for the benchmark stand-alone silica gel/water adsorption chiller. [ABSTRACT FROM AUTHOR]

Purpose: This paper examines the relationships between bank switching and both customer vulnerability and consumer-oriented policies (financial education and disclosure practices). Design/methodology/approach: The analysis employs microdata from the Special Eurobarometer on Financial Products and Services, for 24 European nations. It carries out a probit estimation on the factors explaining propensity of bank switching, focusing on three characteristics associated with customer vulnerability: an advanced age, low educational attainment and residence in a rural or a relatively poor region. Findings: The authors report that the probability of bank switching is significantly lower for three groups of vulnerable customers: the elderly, the less educated and those living in deprived regions. Further the authors identify that national financial education policies and disclosure practices have no significant effects on bank switching. Research limitations/implications: Based on these results, the authors propose more targeted policies recognising customers' heterogeneity are required to increase bank switching behaviour. Originality/value: This paper exploits a unique source of information on bank switching behaviour and customer characteristics across European nations. These data are complemented with information about consumer financial education policies and disclosure practices from the World Bank and geographical, market and regulatory factors at the regional and national levels. The paper contributes to two academic areas. First, it presents further evidence on heterogeneity of bank customer switching behaviour, addressed at improving the understanding of customer vulnerability in banking services. Second, it examines the efficacy of consumer-oriented policies (financial literacy and disclosure practices) in encouraging bank switching. [ABSTRACT FROM AUTHOR]

We present the design of an anthracenyl–naphthyl (ANT‐NAPH) dyad and its application as a luminescent 4‐stage photo switch. Both segments can individually react with singlet oxygen to switch off an optical response. In their initial form the larger ANT component reacts significantly faster and thus an ANTO2‐NAPH stage is turned on, observed by optical response of the remaining NAPH. To reduce its reactivity, ANT is substituted with two pyridine rings. This concept is first investigated and quantified on ANT and NAPH as separated molecules. Upon protonation the reaction of ANT becomes significantly slower. For the three possible pyridyl isomers this effect increases along the order meta

Synthetic duplexes with high stabilities have promising potential for mimicking biomolecular functions and developing supramolecular smart materials. Herein, we describe the synthesis and stimuli‐responsive properties of molecular duplexes derived from indolocarbazole–pyridine (I−P) oligomers. These duplexes adopt nonclassical helical structures, stabilized by I−P hydrogen‐bonding pairs in anhydrous chlorinated solvents. Notably, the longest duplex 62 (11‐mer)2 displays remarkable stability, forming twenty hydrogen bonds; its exchange energy barrier was determined to be ΔG≠=22.0 kcal ⋅ mol−1 at 75 °C in anhydrous (CDCl2)2. Upon the addition of water, a hydrated duplex 62 (11‐mer)2⊃10H2O was formed, with one water molecule inserted between each I−P hydrogen‐bonding pair. The Hill coefficient (n) for this process is 6.1, demonstrating extremely positive cooperativity. Conversely, the hydrated duplex 62 (11‐mer)2⊃10H2O was completely converted into the original anhydrous duplex 62 (11‐mer)2 when the temperature was increased. Interconversion between these two distinct duplexes can be repeatedly carried out by varying the temperature. Furthermore, reversible switching between hetero‐duplexes and homo‐duplexes was also demonstrated by controlling the temperature, with concomitant changes in the characteristic emission signals. [ABSTRACT FROM AUTHOR]

Sensitivity of eigenvectors and eigenvalues of symmetric matrix estimates to the removal of a single observation have been well documented in the literature. However, a complicating factor can exist in that the rank of the eigenvalues may change due to the removal of an observation, and with that so too does the perceived importance of the corresponding eigenvector. We refer to this problem as "switching of eigenvalues". Since there is not enough information in the new eigenvalues, post observation removal, to indicate that this has happened, how do we know that this switching has occurred? In this article, we show that approximations to the eigenvalues can be used to help determine when switching may have occurred. We then discuss possible actions researchers can take based on this knowledge, for example making better choices when it comes to deciding how many principal components should be retained and adjustments to approximate influence diagnostics that perform poorly when switching has occurred. Our results are easily applied to any eigenvalue problem involving symmetric matrix estimators. We highlight our approach with application to two real data examples. [ABSTRACT FROM AUTHOR]

Many researchers have focused on molecular electronics, and this field can progress faster by applying semiconductors to molecular modeling. In this work, two middle rings of a bipyridine–biborinine molecular diode are rotated from 25∘ to 90∘ such that the current along the molecule is reduced. The current is minimum and almost zero at 90∘, while it is maximum at 25∘. Accordingly, considering these two angles, the molecule can act as a switching device when the two middle rings are rotated. The bipyridine–biborinine molecular diode is modeled considering the effect of rotation by including two resistors in the model. Two parallel diodes are used in this modeling for pyridine and borinine rings. The ideality factors of these diodes are varied based on the electronegativity of pyridine and borinine rings. This model is then applied to consider different molecular logic gates such as NAND, NOR, NOT, OR and AND gates, as well as molecular logic circuits (half adder and full adder), using the unique capabilities of the LTspice software. [ABSTRACT FROM AUTHOR]

In an ecosystem, harvesting infected prey can assist in managing and containing the spread of the illness within the prey species. On the other hand, the harvesting of predators can be beneficial as it regulates their numbers, preventing them from over-consuming prey and subsequently preserving existence of the prey population. This study introduces a predator–prey model that encompasses prey infection, predator–prey interactions influenced by fear, switching and harvesting. We derive an analytic expression for the basic reproduction number, a critical determinant of disease spread. We investigate the global stability of disease-free and endemic equilibria contingent on the basic reproduction number’s value, highlighting the potential for disease eradication by maintaining it below unity. In-depth analysis of the deterministic model is undertaken, with a focus on Hopf bifurcations that delineate thresholds for disease-free and endemic states. Furthermore, the deterministic model is extended to incorporate environmental stochasticity. We obtain the conditions under which population extinction occurs. Our findings elucidate how the intensity of environmental noise influences population dynamics, providing valuable insights into extinction risks under varying noise levels. [ABSTRACT FROM AUTHOR]

This paper presents aspects related to the indirect thermographic measurement of a C2M0280120D transistor in pulse mode. The tested transistor was made on the basis of silicon carbide and is commonly used in many applications. During the research, the pulse frequency was varied from 1 kHz to 800 kHz. The transistor case temperature was measured using a Flir E50 thermographic camera and a Pt1000 sensor. The transistor die temperature was determined based on the voltage drop on the body diode and the known characteristics between the voltage drop on the diode and the temperature of the die. The research was carried out in accordance with the presented measuring standards and maintaining the described conditions. The differences between the transistor case temperature and the transistor die temperature were also determined based on simulation work performed in Solidworks 2020 SP05. For this purpose, a three-dimensional model of the C2M0280120D transistor was created and the materials used in this model were selected; the methodology for selecting the model parameters is discussed. The largest recorded difference between the case temperature and the junction temperature was 27.3 °C. The use of a thermographic camera allows the transistor's temperature to be determined without the risk of electric shock. As a result, it will be possible to control the C2M0280120D transistor in such a way so as not to damage it and to optimally select its operating point. [ABSTRACT FROM AUTHOR]

Purpose: To evaluate the efficacy and safety of switching from adalimumab originator (Humira, AbbVie) to SB5, adalimumab biosimilar (Adalloce, Samsung Bioepis) in patients with noninfectious uveitis (NIU). Methods: Fifteen patients (29 eyes) with NIU who were switched from adalimumab originator to SB5 and followed up for 6 months or longer were retrospectively included. Data consisted of best-corrected visual acuity (BCVA, logMAR), intraocular pressure (IOP, mmHg), anterior chamber (AC) cell grade, anterior vitreous (AV) cell grade, vitreous haze grade, central macular thickness (CMT, μm), and macular volume (MV, mm3) at pre-switching, 2, 4, and 6 months post-switching. Results: There were no significant differences in BCVA, AC and AV cell grades, and vitreous haze grades at 2, 4, and 6 months post- compared with pre-switching, and no significant differences in CMT and MV at 2 and 6 months post-switching. CMT and MV decreased from 260.55 ± 67.44 μm and 8.37 ± 1.14 mm3 at pre-switching to 244.14 ± 60.31 μm (p = 0.032) and 8.11 ± 1.20 mm3 (p = 0.027) at 4 months post-switching, respectively. There was no recurrence of uveitis, as defined by AC cell grade, vitreous haze, or BCVA. Four patients (27%) were switched back to adalimumab originator after a mean of 9 weeks, due to discomfort during the injection (three patients) and technical difficulty with the new injection device (one patient). No other adverse events occurred after switching to SB5. Conclusion: Switching from adalimumab originator to SB5 for NIU does not result in clinically significant differences in treatment efficacy and safety. [ABSTRACT FROM AUTHOR]

Objective: We conducted two empirical studies (in a cross-sectional and a longitudinal design) with the aim at establishing normative data (including norms for strategy use [i.e., clustering and switching strategies] and performance over time), and examining the convergent validity, the test–retest reliability (3–4 wks interval) and the changes in performance with practice (1 year interval) of the different verbal fluency (VF) quantitative and qualitative scores in Spanish-speaking children and adolescents. Method: In S1 (n = 620 6- to 15-year-old Spanish-speaking children and adolescents), MANCOVA and Pearson's correlations were employed. In S2 (n = 148 6- to 12-year-old Spanish-speaking children), intraclass correlation coefficient (ICC), paired t-tests, and Confirmatory Factor Analysis (CFA) were used. Results: S1 results showed an age effect on all VF measures (quantitative and qualitative). The number of switches/clusters was more related to total word productivity and to executive functions (EF) than the mean cluster size. In S2, a significant increase in phonological VF performance was observed on number of switches and word productivity scores from baseline (Time 1) to repeat testing at Time 2. Practice effects were observed at Time 3 on all measures except for semantic and phonological mean cluster size. Test–retest reliability coefficients at Time 2 for number of clusters and switches, but not for mean cluster size, fell in the moderate range, ranging from ICCs.61 to ICCs.81. Test–retest reliability coefficients for total word productivity were higher (ICCs above.80) and stronger when testing as a unity with CFA methods (ϕ=.94, p <.001). Conclusions: These data may be relevant for informing the neuropsychological assessment of spontaneous cognitive flexibility in children with typical development (TD) and those with developmental or acquired disorders. [ABSTRACT FROM AUTHOR]

In Riociguat rEplacing PDE5i therapy evaLuated Against Continued PDE5i thErapy (REPLACE) (NCT02891850), improvements in risk status were observed in patients with pulmonary arterial hypertension (PAH) at intermediate risk switching to riociguat versus continuing phosphodiesterase-5 inhibitors (PDE5i). This post hoc study applied the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL) Lite 2 and Comparative Prospective Registry of Newly Initiated Therapies for Pulmonary (COMPERA) 2.0 risk-assessment tools to REPLACE to investigate the impact of baseline risk status on clinical improvement. The proportions of riociguat- and PDE5i-treated patients achieving the primary end-point at REVEAL Lite 2 low, intermediate, and high baseline risk reflected the overall population. Proportions of riociguat-treated patients achieving the primary end-point were comparable between the COMPERA 2.0 intermediate-low risk (39%) and intermediate-high risk (43%) groups. Our findings show that patients in REPLACE achieved clinical improvement by switching from PDE5i to riociguat across all COMPERA 2.0 and most REVEAL Lite 2 baseline risk strata. [Display omitted] [ABSTRACT FROM AUTHOR]

Introduction: Persistence on advanced therapies in ulcerative colitis (UC) is a useful real-world treatment performance measure. This study compared real-world persistence during the maintenance phase among advanced therapy-naïve and -experienced patients with UC initiated on ustekinumab or adalimumab. Methods: Claims data from the IQVIA PharMetrics® Plus de-identified database (01/01/2015–06/30/2022) were used to select adult patients with UC treated with ustekinumab or adalimumab based on the agent first initiated (index date) after 10/21/2019. Inverse probability of treatment weighting was used to balance cohorts on baseline characteristics. Persistence on the index agent (no gaps in days of supply of > 120 days for ustekinumab or > 60 days for adalimumab), persistence while corticosteroid-free, while on monotherapy, and persistence on the US labeled dose were described and compared during the 12-month period post-index using Kaplan–Meier analysis and Cox proportional hazards models. Outcomes were analyzed separately among advanced therapy-naïve and advanced therapy-experienced patients. Results: At 12 months post-index, advanced therapy-naïve patients receiving ustekinumab (n = 371) had higher persistence on the index agent [83.8% vs. 57.6%, hazard ratio (95% confidence interval) = 3.09 (2.29–4.16); p < 0.001), persistence while corticosteroid-free [2.00 (1.63–2.45); p < 0.001], persistence while on monotherapy [2.67 (2.07–3.44); p < 0.001], and persistence on the labeled dose [4.21 (2.76–6.44); p < 0.001] versus those receiving adalimumab (n = 1726). At 12 months post-index, advanced therapy-experienced patients receiving ustekinumab (n = 693) had higher persistence on the index agent [78.1% vs. 59.2%, 2.44 (1.82–3.26); p < 0.001], persistence while corticosteroid-free [1.24 (1.01–1.54); p = 0.0447], persistence while on monotherapy [2.53 (2.00–3.21); p < 0.001], and persistence on the labeled dose [4.77 (3.09–7.35); p < 0.001] versus those receiving adalimumab (n = 254). Conclusion: This claims-based analysis demonstrated significantly higher treatment persistence, including persistence while corticosteroid-free, persistence while on monotherapy, and persistence on the labeled dose, among both advanced therapy-naïve and advanced therapy-experienced patients with UC initiated on ustekinumab compared to adalimumab. [ABSTRACT FROM AUTHOR]

The switching response in organic electrochemical transistors (OECT) is a basic effect in which a transient current occurs in response to a voltage perturbation. This phenomenon has an important impact on different aspects of the application of OECT, such as the equilibration times, the hysteresis dependence on scan rates, and the synaptic properties for neuromorphic applications. Here we establish a model that unites vertical ion diffusion and horizontal electronic transport for the analysis of the time‐dependent current response of OECTs. We use a combination of tools consisting of a physical analytical model; advanced 2D drift‐diffusion simulation; and the experimental measurement of a poly(3‐hexylthiophene) (P3HT) OECT. We show the reduction of the general model to simple time‐dependent equations for the average ionic/hole concentration inside the organic film, which produces a Bernards‐Malliaras conservation equation coupled with a diffusion equation. We provide a basic classification of the transient response to a voltage pulse, and the correspondent hysteresis effects of the transfer curves. The shape of transients is basically related to the main control phenomenon, either the vertical diffusion of ions during doping and dedoping, or the equilibration of electronic current along the channel length. [ABSTRACT FROM AUTHOR]

This article is devoted to the event‐triggered practical tracking control for a class of high‐order nonlinear systems with serious uncertainties. Remarkably, the serious uncertainties are greatly reflected from the unknown control directions and input powers which give rise to essential obstacles in control design and hence lead to incapability of the traditional control methods on this topic. To solve the control problem, a novel switching event‐triggered control scheme is proposed by a skillful incorporation of logic‐based switching mechanism into the event‐triggered one. Specifically, two pivotal events are smartly chosen to give the event‐triggered mechanism for the determination of the sampling times. In particular, one of the events is used to give the switching varying mechanism, by which the controller parameters are respectively switched in two groups of sequences which are carefully chosen for the compensation of serious uncertainties. Under the proposed switching event‐triggered mechanism, a state‐feedback controller is designed which guarantees that all the signals of the closed‐loop system are bounded while system output practically tracks the reference signal, along with a finite number of switching of controller parameters as well as the exclusion of the Zeno phenomenon. Finally, simulation examples are provided to validate the effectiveness of the proposed theoretical results. [ABSTRACT FROM AUTHOR]

Businesses strive toward winning awards, following the belief that the more times they win an award, the more positive they will be viewed by consumers. However, the current research highlights a context where increasingly winning an award over a period can backfire. Across two experiments, results reveal that although repeatedly winning an award enhances superiority perceptions relative to existing competitors, consumers conclude the award is uncompetitive, which increases the likelihood of switching to newly introduced competitors. This effect holds for primary (e.g., quality) and tangential (e.g., sustainability) awards, is pronounced for those who trust awards, and reveals important marketplace implications. [ABSTRACT FROM AUTHOR]

Nectar-foraging bees change their use of floral resources as plant species appear in the environment and disappear over their lifetimes. The new flowers used may involve different cues and different nectar extraction tactics. Although bumble bees can adapt to changes in floral cues and required tactics, little is known about whether bees prioritize switching tactics or floral cues when deciding which plant species to switch to. In a laboratory assay, we forced common eastern bumble bee, Bombus impatiens , workers either to switch the handling tactic they were using or to continue using the tactic but to switch the colour of artificial flowers foraged on. We examined whether bees' tendency to change their tactics was influenced by how similar in colour novel flowers were to familiar ones. We conducted a 2 × 2 factorial experiment using artificial flowers, manipulating the handling tactic that bees were initially trained to use (legitimate visit or nectar robbing) and the similarity between novel and trained colours (similar or distinct). We found that under most conditions bees preferred to switch flower colours and retain handling tactics. However, when given experience with legitimate visits and when novel flowers were markedly different in colour from those they had experienced previously, bees tended to switch tactics while continuing to forage on flowers of the same colour. These findings suggest that the similarity in colour of a new floral resource to the currently exploited resource and the flower-handling tactic used by bees both play an important role in decision making by foraging bumble bees. • We examined bumble bees' switching decisions to novel types of flowers. • Bees were trained to legitimately visit or rob blue flowers to obtain reward. • Novel (dark blue or yellow) flower rewards required the trained tactic. • Bees switched to dark blue flowers using the trained tactic. • Bees switched to robbing blue flowers when the novel flower was yellow. [ABSTRACT FROM AUTHOR]

Analyzing data from the verbal fluency task (e.g., "name all the animals you can in a minute") is of interest to both memory researchers and clinicians due to its broader implications for memory search and retrieval. Recent work has proposed several computational models to examine nuanced differences in search behavior, which can provide insights into the mechanisms underlying memory search. A prominent account of memory search within the fluency task was proposed by Hills et al. (2012), where mental search is modeled after how animals forage for food in physical space. Despite the broad potential utility of these models to scientists and clinicians, there is currently no open-source program to apply and compare existing foraging models or clustering algorithms without extensive, often redundant programming. To remove this barrier to studying search patterns in the fluency task, we created forager, a Python package (https://github.com/thelexiconlab/forager) and web interface (https://forager.research.bowdoin.edu/). forager provides multiple automated methods to designate clusters and switches within a fluency list, implements a novel set of computational models that can examine the influence of multiple lexical sources (semantic, phonological, and frequency) on memory search using semantic embeddings, and also enables researchers to evaluate relative model performance at the individual and group level. The package and web interface cater to users with various levels of programming experience. In this work, we introduce forager's basic functionality and use cases that demonstrate its utility with pre-existing behavioral and clinical data sets of the semantic fluency task. [ABSTRACT FROM AUTHOR]

Copyright of Journal of Shanghai Jiao Tong University (1006-2467) is the property of Journal of Shanghai Jiao Tong University Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Two‐dimensional materials exhibit significant potential and wide‐ranging application prospects owing to their remarkable tunability, pronounced quantum confinement effects, and notable surface sensitivity. The switching, optoelectronics, and gas‐sensitive properties of the new carbon material poly‐cyclooctatetraene framework (PCF)‐graphene were systematically studied using density functional theory combined with the nonequilibrium Green's function method. First, the diode device based on PCF‐graphene monolayer exhibited an impressive switching ratio of 106, demonstrating excellent diode characteristics. Moreover, in the investigation of the pin junction utilizing monolayer PCF‐graphene, it is noteworthy that significant photocurrent responses were observed in both the zigzag and armchair directions, specifically within the visible and ultraviolet regions. Finally, gas sensors employing monolayer and bilayer PCF‐graphene demonstrate significant chemical adsorption capabilities for NO and NO2. Notably, the maximum gas sensitivity for NO is achieved in monolayer PCF‐graphene, reaching 322% at a bias voltage of 1.0 V. Meanwhile, for bilayer PCF‐graphene‐based gas sensor, the maximum gas sensitivity reaches 52% at a bias voltage of 0.4 V. In addition, the study also examined the influence of various environmental conditions, specifically H2O, O, and OH, on the system under investigation. The obtained results emphasize the multifunctional properties of PCF‐graphene, exhibiting significant potential for various applications, including switching devices, optoelectronic devices, and gas sensors. [ABSTRACT FROM AUTHOR]

We report an isothermal electric field-induced first-order phase transition from a Mott insulator to the metallic state in the epitaxial thin film of V 2 O 3 in the temperature regime below its Mott transition temperature of ≈ 180 K. This isothermal electric field-induced transition is accompanied by interesting electrothermal history effects, which depend on the measurement paths followed in the electric field–temperature phase space. These interesting properties result in tuneable resistive switching and distinct memristive behaviour in V 2 O 3 . A generalized framework of disorder-influenced first-order phase transition in combination with a resistor network model has been used to explain the observed experimental features. These findings promise possibilities for Mott insulators to be used as highly energy-efficient switches in novel technologies such as neuromorphic computing. [ABSTRACT FROM AUTHOR]

Introduction: This study compared the clinical effectiveness of switching from tumor necrosis factor inhibitor (TNFi) to upadacitinib (TNFi-UPA), another TNFi (TNFi-TNFi), or an advanced therapy with another mechanism of action (TNFi-other MOA) in patients with rheumatoid arthritis (RA). Methods: Data were drawn from the Adelphi RA Disease Specific Programme™, a cross-sectional survey administered to rheumatologists and their consulting patients in Germany, France, Italy, Spain, the UK, Japan, Canada, and the USA from May 2021 to January 2022. Patients who switched treatment from an initial TNFi were stratified by subsequent therapy of interest: TNFi-UPA, TNFi-TNFi, or TNFi-other MOA. Physician-reported clinical outcomes including disease activity (with formal DAS28 scoring available for 29% of patients) categorized as remission, low/moderate/high disease activity, as well as pain were recorded at initiation of current treatment and ≥ 6 months from treatment switch. Fatigue and treatment adherence were measured ≥ 6 months from treatment switch. Inverse-probability-weighted regression adjustment compared outcomes by subsequent class of therapy: TNFi-UPA versus TNFi-TNFi, or TNFi-UPA versus TNFi-other MOA. Results: Of 503 patients who switched from their first TNFi, 261 were in TNFi-UPA, 128 in TNFi-TNFi, and 114 in TNFi-other MOA groups. At the time of switch, most patients had moderate/high disease activity (TNFi-UPA: 73%; TNFi-TNFi: 52%; TNFi-other MOA: 60%). After adjustment for differences in characteristics at point of switch, patients in TNFi-UPA group (n = 261) were significantly more likely to achieve physician-reported remission (67.7% vs. 40.3%; p = 0.0015), no pain (55.7% vs. 25.4%; p = 0.0007), and complete adherence (60.0% vs. 34.2%; p = 0.0049) compared with patients in TNFi-TNFi group (n = 121). Similar findings were observed for TNFi-UPA versus TNFi-other MOA groups (n = 111). Conclusion: Patients who switched from TNFi to UPA had significantly better clinical outcomes of remission, no pain, and complete adherence than those who cycled TNFi or switched to another MOA. [ABSTRACT FROM AUTHOR]

Fault diagnosis in power distribution networks is crucial for fault location, enhancement of fault processing efficiency, and reduction of power outage losses. Currently, the impact of switch operations and other interferences is seldomly considered in fault diagnosis algorithm designing and testing, which may lead to frequent mal-function and poor performance in practical applications. In this paper, a detailed analysis and modeling of the transient process of switch operation in distribution networks is proposed with the combination of the Mayr and the Helmer models. The transient waveform of the on-site operation process is compared and analyzed with the simulation waveforms generated in PSCAD. Based on the accuracy verification of the model, typical fault scenarios in distribution networks, including switch operation processes, are constructed for fault diagnosis algorithm tests. Compared to the traditional model, the model proposed can simulate and generate disturbance data close to the on-site switch operation process for reliability testing of fault diagnosis algorithms. Finally, several suggestions for optimizing the fault diagnosis algorithm and testing process are proposed through result analysis.

The ability to switch adhesion strength is a highly desirable property for adhesives applied in a wet environment. The major challenges involve the presence of a water layer between the substrate and adhesive, and the incorporation of efficient switching mechanisms. Despite the recent progresses in devising such systems, there exist several intrinsic limitations in the current strategies, such as high residual adhesion, the use of solid–liquid transition, or thin film configurations. Herein, a channeled poly(N‐isopropylacrylamide) (PNIPAm) hydrogel containing bio‐inspired dopamine‐comonomers is reported, which undergoes temperature‐controlled reversible switching of underwater adhesion on both hydrophilic and hydrophobic surfaces. The introduction of microscopic channels inside the hydrogel, achieved by removing a sacrificial agarose network, greatly facilitates water removal from the interface and thus promotes underwater adhesive strength. On glass, the maximum adhesive stress of the channeled hydrogel can reach six times that of hydrogels without channels. Additionally, high switching efficiency and low residual adhesion can be achieved by the thermal phase transition of the PNIPAm network, also demonstrated by the capture and release of lightweight, irregular, fragile, and biological objects using the hydrogel. The channeling strategy provides implications for designing future underwater adhesive systems for, e.g., soft robotics or biomedical applications. [ABSTRACT FROM AUTHOR]

Background: Switching between therapies is a recommended strategy for psoriatic arthritis (PsA) patients who experience treatment failure; however, studies including real-life data are scarce. Objectives: To assess the incidence rate (IR) of switching between biologics and targeted synthetic disease-modifying anti-rheumatic drugs (b/tsDMARDs) due to inefficacy in PsA, and to compare the risk of switching due to inefficacy across different b/tsDMARDs groups. Design: A longitudinal retrospective study, spanning from 2007 to 2022, was conducted on patients with PsA treated with b/tsDMARDs at an outpatient rheumatology clinic. Methods: The primary outcome was switching between b/tsDMARDs due to inefficacy. The independent variable was the exposure to b/tsDMARDs during follow-up. As covariates, clinical, treatment-related, and sociodemographic variables were considered. Survival techniques were run to estimate the IR of switching due to inefficacy per 100 patients*year and confidence interval at 95% (95% CI). Cox multivariate regression analyses were run to assess the risk of b/tsDMARDs switching due to inefficacy, expressed as hazard ratio (HR) and 95% CI. Results: In all, 141 patients were included, with 893.09 patients*year follow-ups. 52.48% of them were females in their fifties. In total, 262 courses of treatment were recorded. During the study period, 56 patients presented 121 switches and 103 related to inefficacy (IR: 11.53 (9.51–13.98)). Tumor necrosis factor-alpha inhibitors (TNFi) showed the lowest IR. In the bivariate analysis, all b/tsDMARDs had more risk of switching compared to TNFi (HR: anti-lL-17 vs TNFi: 2.26 (1.17–4.36); others vs TNFi: 3.21 (1.59–6.45)); however, this statistical significance was no longer present in the multivariate analysis once adjustments were made for the covariates. Still, the final model achieved statistical significance in the following variables: gender, clinical symptoms, prescription year, therapy courses, glucocorticoids, and sulfasalazine. Conclusion: In this study, we did not find differences in the rate of switching due to inefficacy among different groups of b/tsDMARDs. Other concomitant treatments, sociodemographic, and clinical variables were identified as risk factors for switching due to inefficacy. Plain language summary: Changes due to drug failure between biologic therapies: a real-life study in psoriatic arthritis patients Introduction: We wanted to evaluate how often patients with psoriatic arthritis change between different drugs because the drugs weren't working well enough. Additionally, we evaluated which factors could influence the change due to drug failure. The studied drugs are biological therapies that are arthritis-modifying drugs designed early in the last decade to prevent or reduce inflammation caused by the disease. Methods: We included patients from 2007 to 2022 in which their consultant rheumatologist had decided to commence them on biologic therapy. We studied the changes due to drug failure, we also included sociodemographic, clinical and treatments information. Results: The study comprised 141 patients. 52% were women in their fifties. We found that 56 patients change drugs 121 times, with 103 of those changes due to failure drug. This means about 11 out of every 100 patients change their biologic therapy each year. There was no difference in the risk of change between the different studied biologic therapies. Women, those with inflammatory back pain, and those who had tried many different drugs were more likely to change due to drug failure. Using additional therapies like glucocorticoids and sulfasalazine also increased the probability of biologic therapy change. Conclusion: Our work did not find differences in the risk of change due to drug failure among different biologic therapies. [ABSTRACT FROM AUTHOR]

Two-dimensional heterojunction materials show great potential for a wide range of applications with their tunable properties, such as versatility and low-dimensional confinement effects. The electronic structure, transport, and optical properties of Janus WSSe/g-GeC heterojunctions are investigated in-depth using density functional theory combined with a nonequilibrium Green's function approach. The results show that the electronic properties of Janus WSSe/g-GeC heterojunction materials can be effectively tuned by applying vertical and biaxial strain. In particular, when a biaxial strain of ±10% is applied, it can transform the heterojunction from semiconductor properties to metallic properties. In addition, we found that a Janus WSSe/g-GeC heterojunction exhibits excellent optical properties with a strong absorption peak in the visible region. In this heterojunction-based PIN junction, considerable photocurrents are generated in the visible range, especially in the region of 1.7 to 3.1 eV, where significant photocurrent density peaks appear, and the vertical strain can effectively modulate the photocurrent density peaks. In addition, a Janus WSSe/g-GeC heterojunction-based device exhibits excellent performance with a high current switching ratio of 1011 at the biaxial strain of ±10%, showing perfect diode behavior. In summary, by tuning the applied strain, its electronic properties can be effectively tuned and exhibit excellent optical response. Janus WSSe/g-GeC heterojunction materials have great potential for optoelectronic and switching devices. These findings provide important references and guidance for further development of practical applications based on WSSe/g-GeC heterojunctions. [ABSTRACT FROM AUTHOR]

Background: When considering changing hypnotic pharmacotherapy, lemborexant has attracted attention as a candidate due to its effectiveness and safety profile. However, few studies have investigated switching patterns in clinical practice. Research design and methods: We conducted a retrospective cohort study using a nationwide claims database. Patients prescribed a single hypnotic who either subsequently switched to (switching cohort) or were additionally prescribed (add-on cohort) lemborexant between July 2020 and December 2021 were identified. Proportion of successful switching was defined as remaining on lemborexant alone or without any hypnotic at 6 months after lemborexant initiation. Results: The success proportion was 70.1% in the switching cohort (n = 4,861) and 38.6% in the add-on cohort (n = 9,423). In the add-on cohort, the success proportion was lower in patients with a hypnotic history of ≥180 days (31.4%) and in patients whose prescribed hypnotic was a benzodiazepine or non-benzodiazepine (31.5% and 37.6%, respectively). Conclusion: The proportion of successful switching was higher in patients who switched to lemborexant than in those who added lemborexant as a concomitant treatment. The lower success proportion in the add-on cohort might be related to clinically more severe insomnia, and/or a concomitant prescription of benzodiazepine or non-benzodiazepine, from which discontinuation may be challenging. [ABSTRACT FROM AUTHOR]

This letter presents the theoretical investigation by a transmission line model and the physical implementation of a novel frequency reconfigurable microstrip antenna with switchable states. More specifically, by using voltage‐controlled PIN diodes, the antenna can be switched between a radiation state and a low‐scattering state. In the radiation state, the operation frequency of the antenna can be electrically modified between 1.5 and 2.3 GHz by acting on the voltage applied to the varactors. In the low‐scattering state, the antenna achieves a significant in‐band radar cross section reduction, with a maximum value of 26.7 dB. The proposed antenna is fabricated and measured. The validity of the proposed strategy is verified by the good agreement between simulated and measurement results. The antenna designed by the proposed approach has great advantages in the radiation performance, aperture size, profile height and design freedom. This work indicates the feasibility of employing the reconfiguration technique to mnipulate the scattering features of an antenna without deteriorating its radiation characteristics. [ABSTRACT FROM AUTHOR]

The effect of the external electric field on the ground-state tautomerism in 8-(benzo[d]thiazol-2-yl)quinolin-7-ol has been studied by using density functional theory. The compound exists as an enol tautomer (off state) and under the influence of the external electric field a long-range intramolecular proton transfer can occur, placing the tautomeric proton at the quinolyl nitrogen atom (on state). This is a result of the much higher dipole moment of the end keto tautomer and indicates that the external electric field can be used to mimic the implicit solvent effect in tautomeric systems. In the excited state, the further stabilization of the most polar on state leads to a situation when the excited-state intramolecular proton transfer becomes impossible, limiting the intramolecular rotation to the conical intersection region. [ABSTRACT FROM AUTHOR]

Based on the Flory-Huggins theory, we built a theoretical model to study the phase transition behavior of zwitterionic polymer (ZP) brushes regulated by hydration and pH. The theoretical model takes into account the hydration of ZP, as well as the electrostatic effect in the ZP brush system. We found that the volume fraction of ZP brushes increases with the weakening hydration under different pH conditions. With the change of pH, the conformation of the ZP brush changes significantly with the hydration transition behavior, which is due to the excessive net charge（positive or negative） of the pH-regulated ZP chain segment, which results in electrostatic repulsion within the ZP chain and ZP brush swells. In addition, when the ZP chain segment presents too much net charge, it will largely determine the electrostatic potential of the ZP brush system and affect the phase transition behavior of the ZP brush. By investigating the free energy of the system, we also found that the free energy of the ZP brush system shows a maximum value. With the change of pH value, the maximum value of the free energy shows a change, indicating the instability of the system. And then, this leads to a phase transition in the ZP brush system. [ABSTRACT FROM AUTHOR]

Introduction: There is a paucity of real-world studies examining the risks of stroke/systemic embolism (SE) and major bleeding (MB) among non-valvular atrial fibrillation (NVAF) patients switching from warfarin to a direct oral anticoagulant (DOAC). This retrospective study was conducted to compare the stroke/SE and MB risks between patients switched from warfarin to apixaban, dabigatran, or rivaroxaban in real-world clinical practice. Materials and methods: This study used data from four United States commercial claims databases from January 1, 2012 to June 30, 2019. The study population included NVAF patients initially treated with warfarin and switched to apixaban, dabigatran, or rivaroxaban within 90 days of their warfarin prescription ending. Patients were matched 1:1 between the DOACs in each database using propensity scores and then pooled for the final analysis. Cox proportional hazards models were used to calculate the risk of stroke/SE and MB. Results and conclusions: The final population consisted of 2,611 apixaban-dabigatran, 12,165 apixaban-rivaroxaban, and 2,672 dabigatran-rivaroxaban pairs. Apixaban vs. dabigatran was associated with a lower risk of stroke/SE (hazard ratio [HR]: 0.61; 95% confidence interval [CI]: 0.39–0.96) and MB (HR: 0.67; 95% CI: 0.50–0.91). Apixaban vs. rivaroxaban was associated with a similar risk of stroke/SE (HR: 0.88; 95% CI: 0.73–1.07) and a lower risk of MB (HR: 0.60; 95% CI: 0.52–0.68). There was no significant difference in either risk between dabigatran and rivaroxaban. These results provide important insights into how the risks of stroke/SE and MB for NVAF patients vary when switching from warfarin to different DOACs. Key point: • Patients with NVAF may switch to DOACs for effectiveness, safety, or convenience. • Risk of stroke/SE and MB may vary among patients with NVAF who switch to DOACs. • Switching to apixaban had a lower risk of MB than dabigatran/rivaroxaban. • Results may inform DOAC prescribing decisions after warfarin in patients with NVAF. [ABSTRACT FROM AUTHOR]

Background: Biologic agents have demonstrated efficacy in treating ulcerative colitis (UC); however, treatment failure to tumor necrosis factor inhibitors (TNFi) is common in the real world. Data on preferential sequencing in clinical practice after failure remain limited. Objectives: This study aimed to evaluate real-world outcomes of patients cycling to TNFis or switching to non-TNFi biologics following first-line failure with TNFis. Design: Retrospective cohort study in Germany. Methods: Adult patients with UC were identified using administrative claims data from 1 May 2014 to 30 June 2022 provided by a statutory sickness fund. Patients newly initiating first-line therapy with TNFis and then switching to another agent were identified. Patients were defined as within-class switched (WCS), if they cycled to another TNFi, or outside-class switchers (OCS), if they switched to a non-TNFi biologic [ustekinumab (UST) or vedolizumab (VDZ)] and followed from index (switch date) to death, insurance end, or study end on 30 June 2022. Inverse probability of treatment weighting (IPTW) was performed to adjust for differences in baseline characteristics between groups, and weighted Cox regression models were used to compare primary (time to discontinuation and second treatment switch) and secondary outcomes (corticosteroid-free drug survival). Results: We identified 166 patients initiating TNFis and switching to a subsequent treatment (mean age: 42.9 years, 49.4% female). Following IPTW, there were 71 and 76 patients in the WCS and OCS groups, respectively. Compared to OCS, WCS were more likely to discontinue the new therapy [hazard ratio (HR), 1.82, 95% confidence interval (CI), 1.14–2.89, p = 0.012], and switch a second time (HR, 3.46, 95% CI, 1.89–6.36, p < 0.001). Moreover, WCS showed an increased likelihood of initiating prolonged corticosteroid therapy (HR, 1.42, 95% CI, 0.77–2.59, p = 0.260); however, the results were not significant. Conclusion: Following first-line TNFi failure, this study suggests that real-world outcomes among patients with UC are less favorable when cycling to another TNFi, compared to switching to a non-TNFi such as UST or VDZ. [ABSTRACT FROM AUTHOR]

Patients are often switched between generic formulations of the same drug, but in some cases generic interchangeability is questioned. For generic drugs to be approved, bioequivalence with the innovator drug should be demonstrated, but evidence of bioequivalence is not required in the intended patient population or relative to other approved generics. Aim: We aim to identify pathophysiological pharmacokinetic subpopulations for whom there is a difference in comparative bioavailability compared to a healthy population. Methods: We used simulated exposures from a nonparametric model of multiple generics and the originator gabapentin. Exposure was simulated for virtual populations with pharmacokinetic characteristics beyond those of healthy subjects with regard to rate of absorption, volume of distribution and reduced renal function. Virtual parallel design bioequivalence studies were performed using a random sample of 24 simulated subjects, with standard acceptance criteria. Results: Results indicated increased pharmacokinetic variability for patient populations with a lower rate of absorption or a reduced renal function, but no change in the average comparable bioavailability ratio. This increased variability results in a reduced likelihood of demonstrating bioequivalence. Observations were similar for comparisons between all different formulations, as well as between subjects who received the identical formulation in a repeated fashion. No relevant effect was observed for simulations with increased volume of distribution. Conclusion: Our simulations indicate that the reduced likelihood of demonstrating bioequivalence for subjects with altered pharmacokinetics is not influenced by a formulation switch, nor does the average comparable bioavailability ratio change, therefore these results support generic interchangeability and current approval requirements for generics. [ABSTRACT FROM AUTHOR]

Introduction: One strategy to mitigate progressive multifocal leukoencephalopathy (PML) risk is to switch to other highly effective disease-modifying therapies (DMTs). However, the optimal switch DMT following natalizumab (NTZ) discontinuation is yet to be determined. Objective: The objective of the study is to determine the most effective and tolerable DMTs to switch to following NTZ discontinuation due to John Cunningham virus (JCV) antibody positivity. Methods: This is a multicenter observational cohort study that included all stable relapsing-remitting multiple sclerosis (MS) patients who were treated with NTZ for at least 6 months before switching therapy due to JCV antibody positivity. Results: Of 321 patients, 255 switched from NTZ to rituximab/ocrelizumab, 52 to fingolimod, and 14 to alemtuzumab, with higher annualized relapse rate (ARR) in fingolimod switchers (0.193) compared with rituximab/ocrelizumab or alemtuzumab (0.028 and 0.032, respectively). Fingolimod switchers also had increased disability progression (p = 0.014) and a higher proportion developed magnetic resonance imaging (MRI) lesions compared with rituximab/ocrelizumab (62.9% vs. 13.0%, p < 0.001, and 66.6% vs. 24.0%, p < 0.001, respectively). Mean drug survival favored rituximab/ocrelizumab or alemtuzumab over fingolimod (p < 0.001). Conclusion: Our study shows superior effectiveness of rituximab/ocrelizumab and alemtuzumab compared with fingolimod in stable patients switching from NTZ due to JC virus antibody positivity. [ABSTRACT FROM AUTHOR]

In this work, the design, fabrication, static device testing, and double‐pulse switching performance of multi‐finger D‐mode GaN metal–insulator–semiconductor high‐electron‐mobility transistors (MISHEMTs) on silicon are discussed. Utilizing an metal‐organic chemical vapor deposition‐grown GaN high‐electron‐mobility transistors stack with a superlattice buffer, field‐plated devices with a meandering gate geometry and a total gate width of 30 mm are fabricated. Plasma enhanced chemical vapor deposition SiNx is used as the gate dielectric, followed by an optimized bilayer SiNx passivation scheme. Devices with 100 μm gate width have an ON/OFF ratio of ≈108. They are analyzed for dynamic Ron (normalized Ron = 3 at 100 μs) and time‐dependent dielectric breakdown for gate reliability, resulting in a β value of 2.65 from the Weibull plot. Devices with a 30 mm gate width exhibit a maximum ON current of 8 A at zero gate voltage and a three‐terminal breakdown of ≈500 V. The devices are diced, wire‐bonded to a printed circuit board, and a double‐pulsed test is performed for switching transient characterization under clamped inductive load. The OFF‐state and ON‐state energy loss are estimated to be Eon = 14 μJ and EOFF = 27 μJ, respectively, when switched at 5 A, 50 V. In this study, the potential of GaN MISHEMTs with bilayer SiNx passivation for low‐power D‐mode switching applications (5 A, 50 V) is demonstrated. [ABSTRACT FROM AUTHOR]

While studies have explored the feasibility of switching between various thrombopoietin receptor agonists in treating immune thrombocytopenia (ITP), data on the switching from eltrombopag to hetrombopag remains scarce. This post-hoc analysis of a phase III hetrombopag trial aimed to assess the outcomes of ITP patients who switched from eltrombopag to hetrombopag. In the original phase III trial, patients initially randomized to the placebo group were switched to eltrombopag. Those who completed this 14-week eltrombopag were eligible to switch to a 24-week hetrombopag. Treatment response, defined as a platelet count of ≥ 50 × 109/L, and safety were evaluated before and after the switch. Sixty-three patients who completed the 14-week eltrombopag and switched to hetrombopag were included in this post-hoc analysis. Response rates before and after the switch were 66.7% and 88.9%, respectively. Among those with pre-switching platelet counts below 30 × 109/L, eight out of 12 patients (66.7%) responded, while eight out of nine patients (88.9%) with pre-switching platelet counts between 30 × 109/L and 50 × 109/L responded post-switching. Treatment-related adverse events were observed in 50.8% of patients during eltrombopag treatment and 38.1% during hetrombopag treatment. No severe adverse events were noted during hetrombopag treatment. Switching from eltrombopag to hetrombopag in ITP management appears to be effective and well-tolerated. Notably, hetrombopag yielded high response rates, even among patients who had previously shown limited response to eltrombopag. However, these observations need to be confirmed in future trials. [ABSTRACT FROM AUTHOR]

Antiretroviral therapy (ART) can be personalized through simple formulations with high resistance barriers, favorable safety profiles, and novel administration routes. Switching treatments has become a key clinical strategy for addressing drug toxicity and interactions and enhancing adherence and convenience. This strategy aims to improve the quality of life and long-term efficacy, even in challenging cases like people living with HIV (PLWH) with multiple comorbidities, prior virological failure, and drug resistance. The authors reviewed clinical trials and cohort studies providing evidence of benefits and risks of current antiretroviral (ARV) drugs as switching options for PLWH in various scenarios. The literature search included clinical trials, meta-analyses, observational studies, and review articles in English published after 2000, and current HIV treatment guidelines in English and Spanish as of February 2024. New ARV drugs offer advantages in efficacy and safety over previous options but may also have adverse effects. Second-generation integrase inhibitors and tenofovir alafenamide show benefits as switching options in various scenarios, though more research is needed on potential weight gain and metabolic issues. Injectable long-acting ART is promising for switching strategies, but finding the optimal combination of new drugs remains challenging. [ABSTRACT FROM AUTHOR]

Background and Objectives: In this study, our objective was to assess and compare the changes in visual and structural outcomes among patients with neovascular age-related macular degeneration (nAMD) who were switched from intravitreal aflibercept (IVA) to either intravitreal brolucizumab (IVBr) or intravitreal faricimab (IVF) injections in a clinical setting. Materials and Methods: This observational clinical study included 20 eyes of 20 patients switched to brolucizumab and 15 eyes of 14 patients switched to faricimab from aflibercept in eyes with nAMD. We measured the structural outcome (central macular thickness (CMT)) and the visual outcome (best-corrected visual acuity (BCVA); logMAR) as follows: just before the most recent IVA injection (B0), one month after the most recent IVA injection (B1), just before the first IVBr or IVF injection (A0), one month after (A1) and three months after (A3) the first IVBr or IVF injection. Results: BCVA showed significant improvement at A1 (0.25 ± 0.34) and at A3 (0.19 ± 0.24) compared to A0 (0.38 ± 0.35) in the IVBr group (p = 0.0156, p = 0.0166, respectively). CMT (μm) was significantly thinner at A1 (IVBr: 240.55 ± 51.82, IVF: 234.91 ± 47.29) and at A3 (IVBr: 243.21 ± 76.15, IVF: 250.50 ± 72.61) compared to at A0 (IVBr: 303.55 ± 79.18, IVF: 270.33 ± 77.62) in the IVBr group (A1: p = 0.0093, A3: p = 0.0026) and in the IVF group (A1: p = 0.0161, A3: p = 0.0093). There was no significant difference in BCVA and CMT improvement observed between two groups at any time point (p > 0.05 for all). Conclusions: Switching from aflibercept to either brolucizumab or faricimab has a significant anatomical effect in eyes with nAMD and both treatments appear to be effective short-term treatment options. There is a trend towards greater visual improvements and reductions in CMT with brolucizumab. [ABSTRACT FROM AUTHOR]

Introduction: Contraceptive switching from a more effective to a less effective method is a concern, especially in developing countries with high unmet needs for family planning. Indeed, the lack of understanding regarding the reasons behind contraceptive switching behavior in the study area poses a significant challenge in effectively addressing this issue. Objective: This study aimed to assess the magnitude and factors associated with long-acting contraceptive switching in Mizan-Aman town, southwest Ethiopia. Methods: A community-based cross-sectional study was conducted, involving 345 women randomly selected from the population of married women in their reproductive age group. Data collection was conducted through interviewer-administered questionnaires. Bivariate and multivariable logistic regression analyses were employed to ascertain factors linked with contraceptive method switching status. Statistical significance was determined at a P -value of less than.05. Results: Out of the 345 participants interviewed, the prevalence of switching from long-acting to short-acting contraceptives was 28.4%, 95% CI (13.6%, 33.2%). Upon adjusting for confounding variables, factors significantly associated with contraceptive switching included women aged 31–35 [adjusted odds ratio (AOR) = 0.58; 95% CI (0.36, 0.74)] and aged 41–49 [AOR = 0.54; 95% CI (0.48, 0.82)], those with formal education [AOR = 0.79; 95% CI (0.52, 0.87)], those desiring future pregnancy [AOR = 2.12; 95% CI (1.98, 3.38)], experiencing complications from previous method use [AOR = 3.67; 95% CI (2.57, 7.40)], and encountering stockouts of their preferred contraceptive choice [AOR = 2.01; 95% CI (1.39, 3.24)]. Conclusion and recommendation: The study area exhibited a notable prevalence of switching from long-acting contraceptives. Complications arising from prior method use and the unavailability of preferred contraceptive options emerged as significant factors influencing this switching behavior. Thus, it underscores the importance of providing counseling and ongoing support to women, ensuring access to safer and more effective modern contraceptive methods. [ABSTRACT FROM AUTHOR]

This paper is devoted to the time-varying formation control of multiple marine surface vessels (MSVs) with input saturation. More serious uncertainties are involved than the related literature since external disturbance is considered while all the system parameters are unknown. Moreover, different from the severe constraints on the formation patterns and the leader's dynamics in the related literature, rather fairly weak conditions are required since the relative deviations are only first but not more order continuously differentiable which imply that a wider class of formation patterns can be allowed, while the time derivatives of relative deviations as well as the leader's output are not necessarily available for feedback. These two aspects make the traditional control methods on this topic ineffective. Then, by combining vectorial backstepping control method with logic-based switching mechanism, a switching controller is successfully designed for the formation control in this paper. It is worthwhile pointing out that, by the skilful design of a switching mechanism, the serious uncertainties are compensated while the severe assumptions on the formation patterns of the related literature are relaxed. Finally, simulation results are first provided to validate the effectiveness of the proposed theoretical results, and then a comparison with PID method is given to show the superiority of the proposed method. [ABSTRACT FROM AUTHOR]

Objectives To assess the effectiveness and tolerability of first- and second-line interleukin (IL)-17A inhibitor treatment in PsA patients from 2014 to 2021 using data from the Danish Rheumatology Registry (DANBIO) by investigating adherence to therapy. Method PsA patients recorded in the DANBIO who received a first- or second-line IL-17A inhibitor treatment were included in this study. All patients included had previously received one or more TNF inhibitor treatment. Baseline characteristics were analysed in subgroups as first-line IL-17A inhibitor treatment and second-line IL-17A inhibitor treatment. Adherence to therapy of first- or second-line IL-17A inhibitor treatments was reported as Kaplan–Meier plots. Results A total of 534 patients were included in the study, with 534 first-line switchers (secukinumab: 510, ixekizumab: 24) and 102 second-line switchers (secukinumab: 35, ixekizumab: 67). Baseline characteristics showed a similar HAQ and visual analogue scale (VAS) for pain. VAS global, 28-joint DAS with CRP and the previous number of biologic DMARD treatments were similar, with a greater value for second-line switchers. First-line ixekizumab-treated patients present a younger age, greater percentage of females, a lower disease duration and a lower CRP value. Concomitant MTX use was greater for the first-line secukinumab-treated patients. First- and second-line switchers had a similar adherence to therapy. Second-line secukinumab and second-line ixekizumab switchers showed a similar adherence to treatment. Conclusion PsA patients receiving first- or second-line IL-17A inhibitors showed homogeneous baseline characteristics and similar adherence to therapy. Treatment failure of the first IL-17A inhibitor treatment should not preclude a second-line IL-17A inhibitor treatment. [ABSTRACT FROM AUTHOR]

Interfacial engineering is important for ferroelectric thin-film heterostructures because of the modulation of boundary conditions of the spontaneous polarizations and their switching behaviors, which are essential for ferroelectric electronics. In this work, we study the effects of interfacial buffering layer, 5-nm-thick SrTiO3 (STO), on the imprint and domain switching of epitaxial Pt/Pb(Zr,Ti)O3/SrRuO3 (SRO) thin-film heterostructures and capacitors. By buffering the ultrathin SrTiO3 layer at the Pb(Zr,Ti)O3 surface, the imprint effect can be dramatically alleviated as observed in the piezoresponse force microscopy (PFM)-measured domain structures and polarization–electric field hysteresis loops in thin-film capacitors. However, when the SrTiO3 layer is buffered at the Pb(Zr,Ti)O3/SrRuO3 interface, the imprint effect is slightly increased. These phenomena are explained based on the band alignments among the Pt and SrRuO3 electrodes and the Pb(Zr,Ti)O3 layer associated with the existence of oxygen vacancies in the SrTiO3 layer. With the reduction of imprint effect, the domain switching dynamics are also improved in the SrTiO3-buffered Pb(Zr,Ti)O3 capacitor, in which the switching activation field is decreased by about 45.3% in comparison with that of the pristine capacitor. These results facilitate the design and optimization of ferroelectric devices with the improvements in domain configurations, switching behaviors and band alignments. [ABSTRACT FROM AUTHOR]

In the paper, a generalized Lotka–Volterra-type system with switching is considered. The conditions for the ultimate boundedness of solutions and the permanence of the system are studied. With the aid of the direct Lyapunov method, the requirements for the switching law are established to guarantee the necessary dynamics of the system. An attractive compact invariant set is constructed in the phase space of the system, and a given region of attraction for this set is provided. A distinctive feature of the work is the use of a combination of two different Lyapunov functions, each of which plays its own special role in solving the problem. [ABSTRACT FROM AUTHOR]

This research paper introduces an innovative modulation technique for controlling a 3-level flying capacitor multilevel inverter (FCMLI), aiming to streamline the modulation process in contrast to conventional methods. The proposed simplified modulation technique paves the way for more straightforward and efficient control of multilevel inverters, enabling their widespread adoption and integration into modern power electronic systems. Through the amalgamation of sinusoidal pulse width modulation (SPWM) with a high-frequency square wave pulse, this controlling technique attains energy equilibrium across the coupling capacitor. The modulation scheme incorporates a simplified switching pattern and a decreased count of voltage references, thereby simplifying the control algorithm. [ABSTRACT FROM AUTHOR]

Copyright of Experimental Technology & Management is the property of Experimental Technology & Management Editorial Office and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)

Abstract The switching response in organic electrochemical transistors (OECT) is a basic effect in which a transient current occurs in response to a voltage perturbation. This phenomenon has an important impact on different aspects of the application of OECT, such as the equilibration times, the hysteresis dependence on scan rates, and the synaptic properties for neuromorphic applications. Here we establish a model that unites vertical ion diffusion and horizontal electronic transport for the analysis of the time‐dependent current response of OECTs. We use a combination of tools consisting of a physical analytical model; advanced 2D drift‐diffusion simulation; and the experimental measurement of a poly(3‐hexylthiophene) (P3HT) OECT. We show the reduction of the general model to simple time‐dependent equations for the average ionic/hole concentration inside the organic film, which produces a Bernards‐Malliaras conservation equation coupled with a diffusion equation. We provide a basic classification of the transient response to a voltage pulse, and the correspondent hysteresis effects of the transfer curves. The shape of transients is basically related to the main control phenomenon, either the vertical diffusion of ions during doping and dedoping, or the equilibration of electronic current along the channel length.